07:34 AM EDT, 10/17/2025 (MT Newswires) -- Boston Scientific ( BSX ) said Friday it has agreed to acquire the remaining shares of Nalu Medical it does not own for $533 million in cash.

Nalu develops and commercializes neurostimulation products for chronic pain.

Boston Scientific ( BSX ), which first invested in Nalu Medical in 2017, said the transaction price amounts to $600 million on a 100% basis before consideration of its existing ownership and other closing adjustments.

The acquisition is expected to be completed in the first half of 2026, the company said.

Boston Scientific ( BSX ) said it expects the deal to be immaterial to adjusted earnings per share in 2026, slightly accretive in 2027, and increasingly accretive thereafter.